BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10913291)

  • 1. 8-Substituted cAMP analogues reveal marked differences in adaptability, hydrogen bonding, and charge accommodation between homologous binding sites (AI/AII and BI/BII) in cAMP kinase I and II.
    Schwede F; Christensen A; Liauw S; Hippe T; Kopperud R; Jastorff B; Døskeland SO
    Biochemistry; 2000 Aug; 39(30):8803-12. PubMed ID: 10913291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogs.
    Ogreid D; Ekanger R; Suva RH; Miller JP; Døskeland SO
    Eur J Biochem; 1989 Apr; 181(1):19-31. PubMed ID: 2540965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Rp)- and (Sp)-8-piperidino-adenosine 3',5'-(cyclic)thiophosphates discriminate completely between site A and B of the regulatory subunits of cAMP-dependent protein kinase type I and II.
    Ogreid D; Dostmann W; Genieser HG; Niemann P; Døskeland SO; Jastorff B
    Eur J Biochem; 1994 May; 221(3):1089-94. PubMed ID: 8181466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoleucine 368 is involved in low-affinity binding of N6-modified cAMP analogues to site B of the regulatory subunit of cAMP-dependent protein kinase I.
    Huq I; Dostmann WR; Ogreid D
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):337-43. PubMed ID: 8645227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates.
    Dostmann WR; Taylor SS; Genieser HG; Jastorff B; Døskeland SO; Ogreid D
    J Biol Chem; 1990 Jun; 265(18):10484-91. PubMed ID: 2162349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the carboxyl-terminal regional of the cAMP-dependent protein kinase type I alpha regulatory subunit to cyclic nucleotide interactions.
    Kapphahn MA; Shabb JB
    Arch Biochem Biophys; 1997 Dec; 348(2):347-56. PubMed ID: 9434747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
    Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of two fluorescent cAMP analogues to type I and II regulatory subunits of cAMP-dependent protein kinases.
    Mucignat-Caretta C; Caretta A
    Biochim Biophys Acta; 1997 Jun; 1357(1):81-90. PubMed ID: 9202178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of cAMP-binding site B in the regulatory subunit of cAMP-dependent protein kinase alters the photoaffinity labeling of site A.
    Ringheim GE; Saraswat LD; Bubis J; Taylor SS
    J Biol Chem; 1988 Dec; 263(34):18247-52. PubMed ID: 2848031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity binding of the heat-stable protein kinase inhibitor to the catalytic subunit of cAMP-dependent protein kinase is selectively abolished by mutation of Arg133.
    Wen W; Taylor SS
    J Biol Chem; 1994 Mar; 269(11):8423-30. PubMed ID: 8132568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cAMP-binding site mutations on intradomain cross-communication in the regulatory subunit of cAMP-dependent protein kinase I.
    Ringheim GE; Taylor SS
    J Biol Chem; 1990 Nov; 265(32):19472-8. PubMed ID: 2174038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination. Principles for optimizing the isozyme specificity of analog combinations.
    Ogreid D; Ekanger R; Suva RH; Miller JP; Sturm P; Corbin JD; Døskeland SO
    Eur J Biochem; 1985 Jul; 150(1):219-27. PubMed ID: 2990925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for the chemical interactions of adenosine 3':5'-monophosphate with the R subunit of protein kinase type I. Refinement of the cyclic phosphate binding moiety of protein kinase type I.
    Jastorff B; Hoppe J; Morr M
    Eur J Biochem; 1979 Nov; 101(2):555-61. PubMed ID: 230034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate.
    Downs SM; Hunzicker-Dunn M
    Dev Biol; 1995 Nov; 172(1):72-85. PubMed ID: 7589815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform specific differences in binding of a dual-specificity A-kinase anchoring protein to type I and type II regulatory subunits of PKA.
    Burns LL; Canaves JM; Pennypacker JK; Blumenthal DK; Taylor SS
    Biochemistry; 2003 May; 42(19):5754-63. PubMed ID: 12741833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis.
    Raynaud F; Evain-Brion D; Gerbaud P; Marciano D; Gorin I; Liapi C; Anderson WB
    Free Radic Biol Med; 1997; 22(4):623-32. PubMed ID: 9013125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides.
    Glass DB; Feller MJ; Levin LR; Walsh DA
    Biochemistry; 1992 Feb; 31(6):1728-34. PubMed ID: 1310617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cAMP derivatives with the 'stable' cAMP-binding site in the cAMP-dependent protein kinase type I.
    de Wit RJ; Hoppe J; Stec WJ; Baraniak J; Jastorff B
    Eur J Biochem; 1982 Feb; 122(1):95-9. PubMed ID: 6277633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the function of the two different intrachain cyclic AMP binding sites of heart protein kinase.
    Rannels SR; Corbin JD
    Adv Myocardiol; 1982; 3():531-9. PubMed ID: 6302788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping adenosine cyclic 3',5'-phosphate binding sites on type I and type II adenosine cyclic 3',5'-phosphate dependent protein kinases using ribose ring and cyclic phosphate ring analogues of adenosine cyclic 3',5'-phosphate.
    Yagura TS; Miller JP
    Biochemistry; 1981 Feb; 20(4):879-87. PubMed ID: 6260142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.